Visiting Biosurfit, the first startup to benefit from the 200M Fund investment

Today we are participating in the government’s visit to Biosurfit, in Azambuja.

Focused on the development and manufacture of IVD (in vitro diagnostics) tests at the Point-of-Care with highly innovative technology and with about 100 qualified workers, Biosurfit was the first Portugal based startup to benefit from the 200M Fund investment.

In a partnership with Boule Diagnostics investing EUR 5 million and another EUR 5 million invested by 200M, Biosurfit raised a total of EUR 10 million in capital to support the growth of the current business into different worldwide markets and to continuously research and develop new products.